drug-injecting microneedles
Scope
Date
~
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Capital raising
CJ Bioscience conducts paid-in capital increase of $50 mn
South Korea's CJ Bioscience Inc., a pharmaceutical company specializing in intestinal microorganisms called microbiomes, will conduct a paid-in capi...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB submits new drug application to FDA for Rivoceranib liver cancer drug
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn
South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...
May 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Hydrogen economy
Hanyang, Linde to inject $800 mn for hydrogen cluster in Korea
Hanyang Corporation Ltd., a South Korean construction firm, will join forces with German industrial gases and engineering company Linde AG to create...
May 05, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets marketing approval for epilepsy drug in Israel
South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...
May 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
LG Chem in talks with Glenwood to sell off diagnostics unit
LG Chem Ltd. is slated for exclusive talks with Seoul-based Glenwood Private Equity to sell off its in vitro diagnostics business, according to biop...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to invest $1.8 billion, seeks M&As for inorganic growth
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, plans to spend 2.4 trillion won ($1.8 billion) over the next five years and...
Apr 28, 2023 (Gmt+09:00)
-
Pension funds
Korea’s GEPS to begin investing in global buyout, growth funds
South Korea’s Government Employees Pension Service (GEPS) is set to inject 100 billion won ($74.7 million) to make its first investments in gl...
Apr 28, 2023 (Gmt+09:00)
-
Content platforms
Netflix to inject $2.5 bn in Korean drama series, movies over next 4 years
WASHINGTON, D.C. – US streaming giant Netflix is slated to invest $2.5 billion in South Korea over the next four years to boost its cont...
Apr 25, 2023 (Gmt+09:00)
-
Batteries
POSCO Future M to inject $461 mn to bulk up cathode production
POSCO Future M Co., a unit of South Korean steel giant POSCO Holdings Inc., said on Monday it has decided to invest 614.8 billion won ($460.5 millio...
Apr 24, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Batteries
S.Korea to inject $15 bn in rechargeable battery sector by 2030
South Korea will invest 20 trillion won ($15.1 billion) in the rechargeable battery sector by 2030 to widen its technology gap with global competito...
Apr 20, 2023 (Gmt+09:00)
-
Bio & Pharma
GeneOne Life Science gets patent for coated microneedle tech in China
South Korea’s biopharmaceutical company GeneOne Life Science Inc. on Tuesday said it received a patent from the China National Intellectual Pr...
Apr 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, UK firm to jointly develop autoimmune disease drug
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea sees release of generic diabetes drugs after Forxiga patent expires
South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...
Apr 11, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to use zebrafish in new drug development
South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...
Apr 10, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem to launch new diabetes combination drug Zemidapa
South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...
Apr 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Drug instructions to be provided via QR codes, URLs in S.Korea
South Korea's the Ministry of Food and Drug Safety announced on Friday that it had revised the "Risk Management Plan (RMP) Guidelines" to allow for ...
Mar 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma to merge with anti-cancer drug developer Platbio
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...
Mar 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Biosimilar giant Celltrion to transform into drug developer
South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Biorchestra signs tech transfer deal for drug delivery system
Biorchestra Co., a South Korean company specializing in RNA-based therapeutics, announced on Tuesday that it has entered into a joint research and o...
Mar 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK
South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Kwangdong introduces new drug candidate for pediatric myopia
South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it has signed a contract with Hong Kong-based Zhaoke Ophthalmo...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's microneedle maker Raphas to enter US market
South Korea's microneedle maker Raphas Co. is expediting its entry into the American pharmaceutical market after entering the country's cosmetics se...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm
ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...
Mar 24, 2023 (Gmt+09:00)
-
Banking & Finance
KB Financial Group injects $385.6 million into S.Korea’s real estate PF
South Korea’s KB Financial Group on Monday said it will provide liquidity support for the domestic market for real estate project financing (P...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)